Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis

Trial Profile

Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Budesonide (Primary) ; Budesonide/mesalazine (Primary) ; Mesalazine (Primary)
  • Indications Ulcerative proctitis
  • Focus Therapeutic Use
  • Sponsors Dr Falk Pharma
  • Most Recent Events

    • 19 Oct 2016 Primary endpoint (Resolution of clinical symptom) has been met,according to the Results presented at the 24th United European Gastroenterology Week.
    • 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week
    • 20 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top